Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth, shares how health care leaders are advancing value-based care through improved data strategies, ...

The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...

Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.

Excessive use of digital devices and mental health issues can both contribute to the development of dry eye syndrome.

New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with ...

Rosalind Franklin University Chicago Medical School and founder and director of the Center for Medical Dermatology/Immunology ...

Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy, highlights key policy updates that are impacting managed care pharmacy.

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission.

US migrant populations experience various dermatologic conditions linked to exposures before, during, and after migration, ...

Carla Nester, MD, MSA, FASN, is coinvestigator for the ongoing APPEAR-C3G trial (NCT04817618), data from which were used to ...

Patients with advanced epithelial ovarian cancer who were non-Hispanic Black, older, had lower household income, resided in ...